Navigation Links
Complete Genomics releases proof-of-concept data for its sequencing technology for the first time
Date:2/6/2009

MOUNTAIN VIEW, Calif. Feb. 6, 2009 Complete Genomics, Inc. released proof-of-concept (PoC) data for its human genome sequencing technology for the first time yesterday evening. The analysis results were reviewed by Dr. Clifford Reid, Complete Genomics chairman, president and CEO, during his presentation at the annual Advances in Genome Biology and Technology Meeting held at the Marco Island Marriott Beach Resort, Marco Island, Fla.

Complete Genomics successfully sequenced a Caucasian HapMap sample (Coriell catalog # NA07022; cell line DNA), generating 91x average read coverage of the genome in a matter of days.

This represents the first human genome sequence produced with a third-generation technology and the work was conducted in-house at Complete Genomics' genome center.

Complete Genomics' system delivered unprecedented throughput, producing 254 Gigabases (Gb) of mapped data (reads), which is the most reported for one human genome.

This technology also demonstrated an average run rate of more than 70 billion mapped bases (70 Gb) per run or 8.8 Gb per machine run per day. The entire sequencing process required nine machine runs with a single run taking just eight days. Furthermore, this analysis was conducted on data generated by Complete Genomics' research and development sequencers; the company's production throughput is expected to increase three fold (up to 200 Gb per run) following its commercial launch in June 2009.

"We were able to make high-confidence base calls for 92 percent of the genome," said Dr. Rade Drmanac, chief scientific officer at Complete Genomics. "As expected, the 8 percent that we did not call included long repeats and duplications, which are difficult for all short-read technologies to sequence. We were able to call alleles for both parental chromosomes for 91 percent of the genome. Sequencing this remaining fraction of DNA will require our Long Fragment Read (LFR) technology additio
'/>"/>

Contact: Lisa Osborne
lisao@waggeneredstrom.com
202-261-7806
Complete Genomics
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Sequencing of sorghum genome completed
2. DOE Joint Genome Institute completes soybean genome
3. Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate
4. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
5. Vaccine against HER2-positive breast cancer offers complete protection in lab
6. L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
7. bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC
8. bioMETRX, Inc. Completes Sequiam Asset Purchase
9. Census of Marine Life lists 122,500 known species, over halfway to complete inventory by Oct. 2010
10. Preliminary DNA analysis completed on California wolverine
11. Internationally recognized experts presents a complete overview on hydroecology and ecohydrology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... consumers to make ethical choices such as buying clothing ... on fair-trade coffee, and bringing their own bags when ... the Journal of Consumer Research , ethical consumption ... their emotions about unethical practices into action. , "Advocates ... environmental and human costs of the products they choose, ...
(Date:9/16/2014)...  Valencell, Inc., a leader in performance biometric data ... "Showcase Companies" representing North Carolina,s ... Venture Conference on September 16-17 th at the ... Raleigh, North Carolina . Valencell,s President Dr. ... the "Digital Health Spotlight Sector" on how the Company,s ...
(Date:9/16/2014)... of wild foods, autumn harks a season of bounty. ... luring intrepid collectors to woodlands in search of elusive ... in the allure of the treasure hunt, and their ... existence. But are the mushrooms which you are eating ... diverse yet vastly underdocumented although some estimates range ...
Breaking Biology News(10 mins):Why are consumers willing to spend more money on ethical products? 2Valencell, Inc. Selected as 'Showcase Company' at CED Tech Venture Conference 2014 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 3
... Over 50 leading experts will meet today in Brussels, ... cocoa flavanol research and the key findings of FLAVIOLA ... flavanols, their health benefits and potential applications. Members of ... of international researchers to review the outcomes of FLAVIOLA,s ...
... What cancerous conditions lead to what kinds of bacterial infections? ... benefit from pre-treatment with certain kinds of antibiotics. A University ... of the International Journal of Infectious Diseases shows ... are especially prevalent in patients with lung and GI ...
... that are socially isolated during a critical period of ... alcohol, found researchers at The University of Texas at ... the socially isolated rats. These effects, which are ... persist even after the rats are reintroduced into the ...
Cached Biology News:Recent breakthroughs in cocoa flavanol research discussed by European research consortium and expert panel 2Planning for bacteria in cancer patients may help hospitals fight infections 2Socially isolated rats are more vulnerable to addiction, report researchers 2Socially isolated rats are more vulnerable to addiction, report researchers 3
(Date:9/17/2014)... Angeles, CA (PRWEB) September 17, 2014 Escape ... microchip for pets which will alert owners if their pet ... using GPS from an implanted microchip in the pet’s body. ... implantable microchips for pets have been around for many years, ... and are not able to track a pet’s location or alert ...
(Date:9/17/2014)... 17, 2014 NASA’s MESSENGER has just ... Corporation is proud to have one of its latch ... mission is a scientific investigation of the planet Mercury. ... sent there, and has provided a vast amount of ... family of latch valves utilize solenoids that also include ...
(Date:9/17/2014)... The Alliance for Clinical Research ... collaborative building a global system to enhance safety, ... Phase 3 of its Site Accreditation and Standards ... Kalali, Vice-President, Global Head, Neuroscience Center of Excellence ... Quality Integration (CQI) Consulting will lead the effort ...
(Date:9/16/2014)... 16, 2014 This report analyzes the worldwide markets ... Software, Hardware, and Biocontent. The report provides separate comprehensive analytics ... Japan , Europe , ... Rest of World. Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
Breaking Biology Technology:Implantable Microchip for Pets with GPS Tracking - Patent Filed by Escape Alert, LLC. 2Implantable Microchip for Pets with GPS Tracking - Patent Filed by Escape Alert, LLC. 3Global Standards Initiative for Clinical Research Sites Advances 2Global Standards Initiative for Clinical Research Sites Advances 3Global Standards Initiative for Clinical Research Sites Advances 4Global Bioinformatics Industry 2Global Bioinformatics Industry 3Global Bioinformatics Industry 4Global Bioinformatics Industry 5Global Bioinformatics Industry 6Global Bioinformatics Industry 7Global Bioinformatics Industry 8Global Bioinformatics Industry 9Global Bioinformatics Industry 10Global Bioinformatics Industry 11Global Bioinformatics Industry 12Global Bioinformatics Industry 13Global Bioinformatics Industry 14Global Bioinformatics Industry 15Global Bioinformatics Industry 16Global Bioinformatics Industry 17Global Bioinformatics Industry 18Global Bioinformatics Industry 19Global Bioinformatics Industry 20Global Bioinformatics Industry 21Global Bioinformatics Industry 22Global Bioinformatics Industry 23
... ... in Arizona ,with State of the Art 3D Dedicated Neurology Suite, , ... (PRWEB) June 28, 2010 -- ... in the state of Arizona to adopt TrueVision® 3D Surgical Visualization, where multiple 3D ...
... ORLANDO, Fla. , June 26 Orexigen® Therapeutics, ... open-label study demonstrating that treatment with Contrave® resulted in significant improvements ... control of eating in overweight and obese patients with major depression. ... The ...
... 26, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: ... an integrated database of clinical studies that showed no ... (pramlintide acetate) injection use compared to a pooled comparator ... findings were presented at the 70th Annual Scientific Sessions ...
Cached Biology Technology:Cardon Children's Medical Center Adopts TrueVision 3D Surgical Visualization Platform for Department of Pediatric Neurosurgery 2Orexigen(R) Therapeutics Announces That Contrave(R) Reduced Depression Scores and Body Weight in Overweight and Obese Patients With Major Depression 2Orexigen(R) Therapeutics Announces That Contrave(R) Reduced Depression Scores and Body Weight in Overweight and Obese Patients With Major Depression 3Orexigen(R) Therapeutics Announces That Contrave(R) Reduced Depression Scores and Body Weight in Overweight and Obese Patients With Major Depression 4Orexigen(R) Therapeutics Announces That Contrave(R) Reduced Depression Scores and Body Weight in Overweight and Obese Patients With Major Depression 5Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes 2Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes 3Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes 4Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes 5Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes 6Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes 7
Dedicated 29.5" X 18" platforms for Stackable shakers. These platforms are optimized for a particular flask clip size and are sold with a full load of flask clips....
Request Info...
... BioPrime Plus Array CGH Genomic Labeling Systems ... reproducible labeling of genomic DNA samples for ... both indirect and direct labeling formats, the ... provide a flexible solution to your genomic ...
We offer solid and solution phase peptide synthesis including a whole range of modifications. Please send the details of your peptide synthesis need to info@rpeptide.com...
Biology Products: